The study in lung cancer found that tanshinone IIA treatment significantly increased CD4+ and CD4+/CD8+ levels in vivo, as well as NK cell activity, further improving immune function and strengthen anti-tumor effect (Li et al., 2016b). The gene discussed is CD4; the disease is neoplasm.